Investments
124Portfolio Exits
23Funds
7
Want to inform investors similar to The Column Group about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Expert Collections containing The Column Group
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find The Column Group in 1 Expert Collection, including CB Insights Healthcare Smart Money Investors - 2020.
CB Insights Healthcare Smart Money Investors - 2020
25 items
Track the world's top-performing VC investors in healthcare. Firms are presented in alphabetical order.
Research containing The Column Group
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned The Column Group in 2 CB Insights research briefs, most recently on Feb 16, 2021.
Latest The Column Group News
Sep 1, 2023
Orange County Employees Retirement System committed $50m to TCG Crossover Fund II, joining the New Mexico State Investment Council and Rhode Island State Treasury. Register now to read this article and more for free. Email address I accept: Email address A link has been emailed to you - check your inbox. Sign in to your account Email address Nearly there! We have just sent you an email so you can verify your account. Please check your spam or junk folder just in case it’s been delivered there. If you do not receive this within five minutes, please try and sign in again. If the problem persists, please email: subscriptions@peimedia.com . Copyright PEI Media Share with other subscribers Cancel
The Column Group Investments
124 Investments
The Column Group has made 124 investments. Their latest investment was in Carmot Therapeutics as part of their Series E on May 5, 2023.
The Column Group Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
5/25/2023 | Series E | Carmot Therapeutics | $150M | No | 9 | |
2/13/2023 | Series B | Hexagon Bio | $77.3M | No | 8VC, CPP Investments, Nextech, The Column Group, Two Sigma Ventures, and Undisclosed Investors | 2 |
1/6/2023 | Series C | Synthekine | $100M | No | The Column Group, and Undisclosed Investors | 7 |
12/22/2022 | Series C - II | |||||
11/29/2022 | Series A |
Date | 5/25/2023 | 2/13/2023 | 1/6/2023 | 12/22/2022 | 11/29/2022 |
|---|---|---|---|---|---|
Round | Series E | Series B | Series C | Series C - II | Series A |
Company | Carmot Therapeutics | Hexagon Bio | Synthekine | ||
Amount | $150M | $77.3M | $100M | ||
New? | No | No | No | ||
Co-Investors | 8VC, CPP Investments, Nextech, The Column Group, Two Sigma Ventures, and Undisclosed Investors | The Column Group, and Undisclosed Investors | |||
Sources | 9 | 2 | 7 |
The Column Group Portfolio Exits
23 Portfolio Exits
The Column Group has 23 portfolio exits. Their latest portfolio exit was Sagimet Biosciences on July 18, 2023.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
7/18/2023 | IPO | Public | 4 | ||
10/29/2021 | IPO | Public | 7 | ||
7/30/2021 | IPO | Public | 4 | ||
Date | 7/18/2023 | 10/29/2021 | 7/30/2021 | ||
|---|---|---|---|---|---|
Exit | IPO | IPO | IPO | ||
Companies | |||||
Valuation | |||||
Acquirer | Public | Public | Public | ||
Sources | 4 | 7 | 4 |
The Column Group Fund History
7 Fund Histories
The Column Group has 7 funds, including PONOI CAPITAL.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
12/31/2017 | PONOI CAPITAL | Early-Stage Venture Capital | Closed | 1 | |
4/27/2016 | Column Group III | ||||
4/27/2016 | Column Group III-A | ||||
9/16/2014 | Column Group II | ||||
4/30/2008 | Column Group LP |
Closing Date | 12/31/2017 | 4/27/2016 | 4/27/2016 | 9/16/2014 | 4/30/2008 |
|---|---|---|---|---|---|
Fund | PONOI CAPITAL | Column Group III | Column Group III-A | Column Group II | Column Group LP |
Fund Type | Early-Stage Venture Capital | ||||
Status | Closed | ||||
Amount | |||||
Sources | 1 |
The Column Group Team
8 Team Members
The Column Group has 8 team members, including current Founder, Managing Partner, Peter H. Svennilson.
Name | Work History | Title | Status |
|---|---|---|---|
Peter H. Svennilson | Three Crowns Capital, and Nomura Holdings | Founder, Managing Partner | Current |
Name | Peter H. Svennilson | ||||
|---|---|---|---|---|---|
Work History | Three Crowns Capital, and Nomura Holdings | ||||
Title | Founder, Managing Partner | ||||
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
